Scarica l'app Stockscreener
94.86
0.21%
-0.20
Dopo l'orario di chiusura:
94.86
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRUS Giù?
Forum
Previsione
Precedente Chiudi:
$95.06
Aprire:
$95.02
Volume 24 ore:
1.08M
Relative Volume:
0.52
Capitalizzazione di mercato:
$7.17B
Reddito:
$35.93M
Utile/perdita netta:
$-244.56M
Rapporto P/E:
-24.02
EPS:
-3.95
Flusso di cassa netto:
$-157.31M
1 W Prestazione:
-0.02%
1M Prestazione:
+0.75%
6M Prestazione:
+108.44%
1 anno Prestazione:
+89.99%
Intervallo 1D:
$94.77
$95.11
Intervallo di 1 settimana:
$94.58
$95.30
Portata 52W:
$33.19
$95.30
Merus N V Stock (MRUS) Company Profile
Nome
Merus N V
Settore
Industria
Telefono
31 030 253 8800
Indirizzo
YALELAAN 62, 3584 CM UTRECHT
Confronta MRUS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRUS
Merus N V
|
94.86 | 7.20B | 35.93M | -244.56M | -157.31M | -3.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Merus N V Stock (MRUS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-17 | Iniziato | Barclays | Overweight |
| 2025-08-25 | Iniziato | Alliance Global Partners | Buy |
| 2025-02-13 | Iniziato | Piper Sandler | Overweight |
| 2025-02-07 | Iniziato | Wells Fargo | Overweight |
| 2024-11-21 | Iniziato | Goldman | Buy |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-03-28 | Iniziato | Truist | Buy |
| 2024-03-04 | Reiterato | Needham | Buy |
| 2023-11-02 | Iniziato | Canaccord Genuity | Buy |
| 2023-08-21 | Iniziato | TD Cowen | Outperform |
| 2022-08-02 | Iniziato | Stifel | Buy |
| 2022-02-11 | Iniziato | BMO Capital Markets | Outperform |
| 2022-02-10 | Iniziato | Needham | Buy |
| 2021-11-17 | Ripresa | Guggenheim | Buy |
| 2021-06-07 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-04-08 | Iniziato | William Blair | Outperform |
| 2021-03-16 | Iniziato | SVB Leerink | Outperform |
| 2020-06-26 | Iniziato | H.C. Wainwright | Buy |
| 2020-05-27 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-11-20 | Ripresa | Guggenheim | Buy |
| 2019-06-28 | Iniziato | ROTH Capital | Buy |
| 2019-04-12 | Ripresa | Guggenheim | Buy |
| 2019-04-03 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-03-27 | Iniziato | Berenberg | Buy |
| 2018-01-02 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-03-21 | Downgrade | Citigroup | Buy → Neutral |
| 2016-12-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2016-11-07 | Downgrade | Citigroup | Buy → Neutral |
| 2016-06-13 | Iniziato | Citigroup | Buy |
| 2016-06-13 | Iniziato | Guggenheim | Buy |
| 2016-06-13 | Iniziato | Wedbush | Outperform |
Mostra tutto
Merus N V Borsa (MRUS) Ultime notizie
Is Merus N.V. stock resilient to inflationJuly 2025 Catalysts & Smart Investment Allocation Insights - newser.com
Why Merus N.V. (2GH) stock could outperform next year2025 Short Interest & Reliable Momentum Entry Alerts - newser.com
Merus NV’s Financial Stability at Risk Due to Unproven ADClonics Technology and Supply Chain Vulnerabilities - TipRanks
Can Merus N.V. (2GH) stock sustain revenue momentumJuly 2025 Trade Ideas & Proven Capital Preservation Methods - newser.com
Merus NV Faces Uncertainty and Risks Amid Genmab A/S Transaction Delays - TipRanks
Merus (MRUS) Forecasts 58.4% Revenue Growth, Ongoing Losses Challenge Bullish Narratives - simplywall.st
Can Merus N.V. (2GH) stock test all time highsJuly 2025 Volume & Trade Opportunity Analysis Reports - newser.com
Will Merus N.V. (2GH) stock keep high P E multiplesJuly 2025 Catalysts & Real-Time Market Trend Scan - newser.com
Is Merus N.V. stock a buy before product launches2025 Earnings Impact & Momentum Based Trading Ideas - newser.com
Is Merus N.V. stock reversal real or fake2025 Technical Overview & High Accuracy Swing Entry Alerts - newser.com
Merus N.V. $MRUS Shares Sold by Moody Aldrich Partners LLC - MarketBeat
Merus N.V. stock volume spike explainedStop Loss & Expert Verified Movement Alerts - newser.com
Can Merus N.V. stock double in next 5 yearsJuly 2025 Patterns & Verified Technical Signals - newser.com
Will Merus N.V. stock sustain high P E ratiosWeekly Profit Analysis & Daily Chart Pattern Signal Reports - newser.com
What risks investors should watch in Merus N.V. stock2025 Trade Ideas & Real-Time Stock Movement Alerts - newser.com
Merus NV reports results for the quarter ended September 30Earnings Summary - TradingView
Merus stock maintains Market Perform rating at BMO Capital - Investing.com
Merus stock maintains Market Perform rating at BMO Capital By Investing.com - Investing.com UK
Genmab, Merus file US antitrust paperwork - MLex
Merus (NASDAQ:MRUS) Sets New 52-Week HighTime to Buy? - MarketBeat
Assessing Merus (MRUS) Valuation After This Year’s 120% Share Price Rally - simplywall.st
What market sentiment indicators show for Merus N.V. (2GH) stockPortfolio Gains Summary & Free Expert Verified Stock Movement Alerts - newser.com
Market reaction to Merus N.V.’s recent newsJuly 2025 Patterns & Weekly High Momentum Picks - newser.com
Key metrics from Merus N.V.’s quarterly data2025 AllTime Highs & Daily Profit Focused Screening - newser.com
How big funds are accumulating Merus N.V. (2GH) stockDollar Strength & Growth Oriented Trade Recommendations - newser.com
Why Merus N.V. stock remains on buy listsWeekly Gains Report & Free Daily Entry Point Trade Alerts - newser.com
Why Merus N.V. stock appeals to dividend seekers2025 Volatility Report & Community Shared Stock Ideas - newser.com
Will Merus N.V. stock deliver better than expected guidanceJuly 2025 Final Week & Fast Gain Stock Tips - newser.com
Merus NV Hits New 52-Week High of $95.30, Up 77.78% - Markets Mojo
Is Merus N.V. stock attractive for income investors2025 Market Overview & Fast Moving Market Watchlists - newser.com
Merus N.V. $MRUS Shares Bought by State of New Jersey Common Pension Fund D - MarketBeat
Merus N V Azioni (MRUS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):